Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2026-02-09 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
股东会议事规则（2026年2月）
Governance Information Classification · 100% confidence The document is titled as "葵花药业集团股份有限公司 股东会议事规则" which translates to "Sunflower Pharmaceutical Group Co., Ltd. Shareholders Meeting Rules." The content details the rules and procedures for convening and conducting shareholders' meetings, including the rights and responsibilities of shareholders, the process for proposals, voting procedures, meeting records, and post-meeting matters. It references relevant laws and regulations governing shareholder meetings and corporate governance. There is no financial data, earnings information, or report publication mentioned. The document is a governance-related document outlining internal rules and procedures for shareholder meetings, which fits the definition of Governance Information (CGR). The document length is 9337 characters, indicating it is a full document, not a brief announcement or notice.
2026-02-09 Chinese
关于修订《公司章程》及相关议事规则的公告
Governance Information Classification · 95% confidence The document is an announcement regarding the revision of the company's Articles of Association and related meeting rules. It details changes to governance documents such as the Articles of Association, Shareholders' Meeting Rules, and Board Meeting Rules. The document does not contain financial data or results, nor is it a report or transcript. It is a formal announcement about governance changes, specifically about internal rules and board structure. Therefore, it fits the category of Governance Information (CGR). The document length is 2684 characters, which is consistent with an announcement rather than a full report.
2026-02-09 Chinese
关于变更总经理（总裁）及调整专门委员会成员的公告
Board/Management Information Classification · 100% confidence The document is an official announcement from a company regarding changes in its senior management, specifically the resignation of the current general manager (总经理/总裁) and the appointment of a new general manager. It also details adjustments to the members of the board's specialized committees. The document includes biographical information about the newly appointed general manager and confirms compliance with relevant governance rules. There are no financial statements, earnings data, or regulatory filings related to financial performance. The content focuses solely on management changes and governance committee adjustments. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 2629 characters, which is consistent with a detailed management change announcement rather than a full report or brief notice.
2026-02-09 Chinese
关于召开2026年第一次临时股东会的通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a detailed notice about convening the 2026 first extraordinary general meeting (临时股东会) of shareholders for 葵花药业集团股份有限公司. It includes information about meeting time, location, voting procedures, agenda items, registration details, and proxy forms. There is no financial data, earnings, audit information, or management discussion. The document is not a report itself but a formal announcement and instructions for a shareholder meeting. This fits the category of Proxy Solicitation & Information Statement (PSI), as it provides materials sent to shareholders to inform and request votes for the meeting.
2026-02-09 Chinese
董事会议事规则（2026年2月）
Governance Information Classification · 100% confidence The document is titled 葵花药业集团股份有限公司董事会议事规则, which translates to 'Rules of Procedure for the Board of Directors of Kuihua Pharmaceutical Group Co., Ltd.' It details the internal rules, structure, responsibilities, meeting procedures, voting, and decision-making processes of the company's board of directors. There is no financial data, audit information, or report content. It is a governance document outlining the company's board governance practices and procedures. Therefore, it fits the category of Governance Information (CGR). The document length is over 10,000 characters, indicating it is a full governance report, not a brief announcement or summary.
2026-02-09 Chinese
关于收到易活牌益生菌粉注册申请受理通知书的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company regarding the receipt of a registration acceptance notice for a new product from a regulatory authority (国家市场监督管理总局). It details the product name, registration number, application details, and a risk warning about the approval process timeline. There is no financial data, no mention of financial results, no management discussion, no voting results, no share transactions, and no report attached or referenced. The document is an official regulatory announcement about a product registration acceptance, which fits best under Regulatory Filings (RNS) as it is a general regulatory announcement that does not fit other specific categories.
2026-02-02 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.